tiprankstipranks
Trending News
More News >
Cyclacel Pharmaceuticals (CYCC)
NASDAQ:CYCC
US Market

Cyclacel Pharmaceuticals (CYCC) Income Statement

Compare
699 Followers

Cyclacel Pharmaceuticals Income Statement

Last quarter (Q4 2024), Cyclacel Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Cyclacel Pharmaceuticals's net income was $-3.05M. See Cyclacel Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 43.00K$ 420.00K$ 0.00$ 0.00$ 0.00
Gross Profit
$ 43.00K$ 420.00K$ -32.00K$ -43.00K$ -20.00K
Operating Expenses
$ 12.05M$ 25.87M$ 27.66M$ 22.94M$ 10.64M
Depreciation and Amortization
$ 6.00K$ 31.00K$ 32.00K$ 43.00K$ 20.00K
EBITDA
$ -12.00M$ -25.42M$ -27.62M$ -22.69M$ -10.62M
Operating Income
$ -12.00M$ -25.45M$ -27.66M$ -22.94M$ -10.64M
Other Income/Expenses
$ 10.00K$ -98.00K$ 1.74M$ 204.00K$ 955.00K
Pretax Income
$ -11.99M$ -25.55M$ -25.91M$ -22.73M$ -9.68M
Net Income
$ -11.21M$ -22.55M$ -21.20M$ -18.89M$ -8.45M
Per Share Metrics
Basic EPS
$ -5.21$ -26.75$ -32.23$ -31.74$ -34.86
Diluted EPS
$ -5.21$ -26.75$ -32.23$ -31.74$ -34.86
Weighted Average Shares Outstanding
2.15M 850.82K 657.62K 595.08K 242.22K
Weighted Average Shares Outstanding (Diluted)
2.15M 850.82K 657.62K 595.08K 242.22K
Currency in USD

Cyclacel Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis